Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA Kumar Jeetendra | October 26, 2023 Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (cdmo) and a global manufacturer of Active Pharmaceutical Ingredients, announced today another new production site of the Group, the facility located in Caronno Pertusella, near Milan (Italy), has received the Good Manufacturing Practice (gmp) certification – CBPF (Certificado de Boas Práticas de Fabricação) – …
Exploring the Benefits of Multivariate Data Analysis in the Pharma Industry Kumar Jeetendra | October 23, 2023 The pharmaceutical business relies heavily on multivariate data analysis (MVDA) since it offers beneficial insights and advantages in a number of areas related to drug development, quality assurance, and research. The following are some of the main advantages of MVDA use in the pharmaceutical sector: Effective Data Handling: The pharmaceutical sector produces enormous amounts of …
Biosimilars vs. Biologics: Breaking Down the Similarities and Differences Kumar Jeetendra | October 14, 2023 Although both biologics and biosimilars are significant drug classes utilized in healthcare, they differ in terms of their properties, approval processes, and price points. Here’s a breakdown of their similarities and differences: Biologics: Origin: Complex medications known as biologics are derived from living things like bacteria, yeast, or mammalian cells. They consist of medicinal proteins, …
Particle Characterisation Laboratories (PCL): A Milestone Passed for Hyderabad CRO Pioneering Excellence in Particle Analysis Kumar Jeetendra | October 10, 2023 It’s been an exhilarating six months since Particle Characterisation Laboratories (PCL) first opened its doors to the global laboratory research community. Positioned as a hub for cutting-edge particle characterization services, PCL continues in its mission to provide unparalleled access to advanced materials characterisation. A Collaborative Journey At PCL, collaboration remains at the core of its …
Varenicline: the answer to tobacco addiction, currently missing in action Kumar Jeetendra | October 10, 2023 Pharmaceutical Roots is a content series from LGC Standards – investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their history, uses, risks, and mechanisms of action. This month, we look at how varenicline – aka Champix, or Chamtix – appeared to offer a solution to the global ‘tobacco …
Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment Kumar Jeetendra | September 26, 2023 Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec®100/6 (beclometasone 100µg / for moterol 6µg), a fix combination in a pressurized metered dose inhaler (pMDI) for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. Luforbec®100µg/6µg pMDI is indicated for adult asthma and COPD treatment, where …
The Science Behind Extrasensory Perception(esp): Exploring the Unseen Kumar Jeetendra | September 5, 2023 Extrasensory perception (ESP) is perception that occurs in addition to or instead of the recognized sensory systems. This group of phenomena often includes telepathy, or the transmission of thoughts between individuals, clairvoyance, or the paranormal awareness of objects or occurrences not necessarily known to others, and precognition, or knowledge of the future. The scientific research …
Cipla launches CIPLAMED 2.0 – knowledge-sharing platform for Healthcare Practitioners (HCPS) Kumar Jeetendra | August 16, 2023 Mumbai, India; 16th August 2023: Cipla announced the launch of CiplaMed 2.0, an enhanced version of the industry-leading knowledge platform for the medical fraternity. In line with its digital transformation agenda, Cipla is pioneering an integrated omnichannel experience for healthcare professionals that seamlessly combines in-clinic interactions with digital engagement and access to medical information. This …
The weather woman of India: Anna Mani Kumar Jeetendra | August 3, 2023 Anna Mani was a distinguished physicist and meteorologist who worked in India. Anna Mani made a number of significant contributions to the field of meteorology and weather sciences in India. Here are some key points about anna mani: Early Life and Education of Anna Mani: Anna Mani’s birthday is August 23rd, and she was born …
Stock in Gland Pharma soars 5% after the US FDA makes no adverse findings Kumar Jeetendra | July 31, 2023 After receiving a zero-observation certificate from the US drug agency for its Visakhapatnam facility, Gland Pharma’s share price increased by 5.49 percent, closing at Rs 1,365 at 9:23am on July 31. Between July 20 and July 28, the United States Food and Drug Administration (US FDA) inspected the company’s VSEZ Sterile Oncology plant in Visakhapatnam …
Cipla tops BW India’s Most Sustainable Companies Rankings for 2022-23 Kumar Jeetendra | June 30, 2023 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has been ranked 1st in the Pharmaceuticals & Healthcare Sector and 5th in the Top 50 Most Sustainable Companies at the 3rd edition of BW India’s Most Sustainable Companies Awards 2022-23. This recognition acknowledges Cipla’s efforts in the …
Dr. Reddy’s enters the trade generics business in India Kumar Jeetendra | June 23, 2023 Hyderabad, India; June 23, 2023 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced its entry into the trade generics business in India with the launch of its new dedicated division ‘RGenX’. Through this, Dr. Reddy’s aims to provide …
